Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The Prostate

Showing results (551-560 of 6,084) with videos related to

Pageof 609
Sort By:
The Prostate|June 3, 2009
C/EBPbeta regulates metastatic gene expression and confers TNF-alpha resistance to prostate cancer cellsMyoung H Kim, Alena Z Minton, Vikas Agrawal
The Prostate|June 11, 2009
The alchemy of jargon: etymologies of urologic neologisms-part 4: the history of histological nomenclatureLochlan Shelfer
The Prostate|April 29, 2009
The prostatic environment suppresses growth of androgen-independent prostate cancer xenografts: an effect influenced by testosteroneKarin Jennbacken, Heléne Gustavsson, Tajana Tesan, et al.
The Prostate|April 29, 2009
Botulinum toxin type A inhibits the growth of LNCaP human prostate cancer cells in vitro and in vivoGilles Karsenty, Joice Rocha, Simone Chevalier, et al.
The Prostate|April 29, 2009
Liposomal gemcitabine (GemLip)-efficient drug against hormone-refractory Du145 and PC-3 prostate cancer xenograftsPeter Jantscheff, Norbert Esser, Ralph Graeser, et al.
The Prostate|May 6, 2009
Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progressionBo Pang, Hui Zhang, Jian Wang, et al.
The Prostate|December 25, 2008
Bcl-2 mediated modulation of vascularization in prostate cancer xenograftsYoshihisa Sakai, Steve Goodison, Sergei Kusmartsev, et al.
The Prostate|January 1, 2009
Identification of extracellular delta-catenin accumulation for prostate cancer detectionQun Lu, Jiao Zhang, Ron Allison, et al.
The Prostate|July 11, 2008
T40214/PEI complex: a potent therapeutics for prostate cancer that targets STAT3 signalingPriya Weerasinghe, Yifei Li, Yongli Guan, et al.
The Prostate|July 11, 2008
Androgen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancerLye Lin Ho, James G Kench, David J Handelsman, et al.
Pageof 609

Showing results (551-560 of 6,084) with videos related to

Sort By:
Pageof 609
The Prostate|June 3, 2009
C/EBPbeta regulates metastatic gene expression and confers TNF-alpha resistance to prostate cancer cellsMyoung H Kim, Alena Z Minton, Vikas Agrawal
The Prostate|June 11, 2009
The alchemy of jargon: etymologies of urologic neologisms-part 4: the history of histological nomenclatureLochlan Shelfer
The Prostate|April 29, 2009
The prostatic environment suppresses growth of androgen-independent prostate cancer xenografts: an effect influenced by testosteroneKarin Jennbacken, Heléne Gustavsson, Tajana Tesan, et al.
The Prostate|April 29, 2009
Botulinum toxin type A inhibits the growth of LNCaP human prostate cancer cells in vitro and in vivoGilles Karsenty, Joice Rocha, Simone Chevalier, et al.
The Prostate|April 29, 2009
Liposomal gemcitabine (GemLip)-efficient drug against hormone-refractory Du145 and PC-3 prostate cancer xenograftsPeter Jantscheff, Norbert Esser, Ralph Graeser, et al.
The Prostate|May 6, 2009
Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progressionBo Pang, Hui Zhang, Jian Wang, et al.
The Prostate|December 25, 2008
Bcl-2 mediated modulation of vascularization in prostate cancer xenograftsYoshihisa Sakai, Steve Goodison, Sergei Kusmartsev, et al.
The Prostate|January 1, 2009
Identification of extracellular delta-catenin accumulation for prostate cancer detectionQun Lu, Jiao Zhang, Ron Allison, et al.
The Prostate|July 11, 2008
T40214/PEI complex: a potent therapeutics for prostate cancer that targets STAT3 signalingPriya Weerasinghe, Yifei Li, Yongli Guan, et al.
The Prostate|July 11, 2008
Androgen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancerLye Lin Ho, James G Kench, David J Handelsman, et al.
Pageof 609